BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21269648)

  • 21. Incomplete revascularization reduces survival benefit of coronary artery bypass grafting: role of off-pump surgery.
    Synnergren MJ; Ekroth R; Odén A; Rexius H; Wiklund L
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):29-36. PubMed ID: 18603050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
    Head SJ; Mack MJ; Holmes DR; Mohr FW; Morice MC; Serruys PW; Kappetein AP
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):535-41. PubMed ID: 22219412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.
    Mack MJ; Banning AP; Serruys PW; Morice MC; Taeymans Y; Van Nooten G; Possati G; Crea F; Hood KL; Leadley K; Dawkins KD; Kappetein AP
    Ann Thorac Surg; 2011 Dec; 92(6):2140-6. PubMed ID: 21967819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.
    Kappetein AP; Dawkins KD; Mohr FW; Morice MC; Mack MJ; Russell ME; Pomar J; Serruys PW
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):486-91. PubMed ID: 16497510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of early outcomes from randomized and nonrandomized studies.
    Cao C; Manganas C; Bannon P; Vallely M; Yan TD
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):738-47. PubMed ID: 22405674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No major differences in 30-day outcomes in high-risk patients randomized to off-pump versus on-pump coronary bypass surgery: the best bypass surgery trial.
    Møller CH; Perko MJ; Lund JT; Andersen LW; Kelbaek H; Madsen JK; Winkel P; Gluud C; Steinbrüchel DA
    Circulation; 2010 Feb; 121(4):498-504. PubMed ID: 20083683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
    Kang SH; Park KH; Choi DJ; Park KW; Chung WY; Lim C; Kim KB; Kim HS
    Am J Cardiol; 2010 Feb; 105(3):343-51. PubMed ID: 20102946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease.
    Sharony R; Grossi EA; Saunders PC; Galloway AC; Applebaum R; Ribakove GH; Culliford AT; Kanchuger M; Kronzon I; Colvin SB
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):406-13. PubMed ID: 14762348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
    Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
    Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention.
    Valgimigli M; Serruys PW; Tsuchida K; Vaina S; Morel MA; van den Brand MJ; Colombo A; Morice MC; Dawkins K; de Bruyne B; Kornowski R; de Servi S; Guagliumi G; Jukema JW; Mohr FW; Kappetein AP; Wittebols K; Stoll HP; Boersma E; Parrinello G;
    Am J Cardiol; 2007 Apr; 99(8):1072-81. PubMed ID: 17437730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On-pump versus off-pump coronary artery bypass grafting in diabetic patients: a propensity score analysis.
    Srinivasan AK; Grayson AD; Fabri BM
    Ann Thorac Surg; 2004 Nov; 78(5):1604-9. PubMed ID: 15511441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
    J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of drug eluting stent implantation with coronary artery bypass surgery in the treatment of patients with chronic total occlusion and multiple vessel disease.
    Liu W; Ma CS; Kang JP; Du X; Chen F; Zhou YJ; Lü SZ; Huang FJ; Gu CX; Zhu XL
    Chin Med J (Engl); 2011 Apr; 124(8):1169-74. PubMed ID: 21542990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes and risk analyses of coronary bypass for left main disease.
    Cho Y; Shimura S; Aki A; Furuya H; Ueda T
    Asian Cardiovasc Thorac Ann; 2014 Nov; 22(9):1031-8. PubMed ID: 24604554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of incomplete revascularization with long-term survival after off-pump coronary artery bypass grafting.
    Yi G; Youn YN; Joo HC; Hong S; Yoo KJ
    J Surg Res; 2013 Nov; 185(1):166-73. PubMed ID: 23769631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.